Cardiotoxicity after liposomal anthracyclines.
Young
Anne Marie
AM
Department of Oncology, Chelsea and Westminster Hospital, London, UK.
Dhillon
Tony
T
Bower
Mark
M
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008081:Liposomes; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D012514:Sarcoma, Kaposi / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D008081:Liposomes; D004317:Doxorubicin